A2AR antagonist 1
CAS: 443103-97-7
Ref. 3D-TSA10397
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire | |
100mg | To inquire |
Product Information
VIPadenant is a small molecule that has been developed to selectively inhibit the adenosine A2A receptor. It has the ability to modulate immune responses by inhibiting the production of pro-inflammatory cytokines and chemokines in Th17 cells, which are cells that play a role in autoimmune diseases such as multiple sclerosis and rheumatoid arthritis. VIPadenant also inhibits lipase activity and blocks adenosine from binding to its receptors, which may lead to an increased metabolism of fat. The drug has shown an ability to inhibit cancer cell proliferation, and has been patented for use as a potential anti-cancer agent.
Chemical properties
Technical inquiry about: 3D-TSA10397 A2AR antagonist 1
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.